Golden
Juvenescence

Juvenescence

Juvenescence is a venture capital and development company focused on developing therapies targeting aging, age-related disease and regeneration.

Juvenescence is a Douglas, Isle of Man based venture capital and development company. They focus their investments and development on companies developing therapeutic strategies to treat the tissue-specific signature and pathologies of aging and senescence. The strategy includes products targeted at slowing cellular aging, slowing and reversing neurodegeneration, destroying senescent cells, replacing aging organs and editing patient genes.



Investment

Juvenescence has invested in LyGenesis, Souvien Therapeutics, BYOMass, BHB Therapeutics, AgeX Therapeutics, Napa Therapeutics, FoxBio, Insilico Medicine, GenerAIt Pharmaceuticals and Netrapharma. 

Timeline

Funded Companies

Company
Description
Website
Industry
Location
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Alexander Pickett

Managing Director



Benjamin Swerner

Director



Chris Shilling

Project Manager



Christine Curioso

Executive Assistant



Colin Watts

CEO of Juvenescence Life



David Ellam

Chief Financial Officer



Dr. Declan Doogan

Chief Medical Officer



Dr. Gregory Bailey

Chief Executive Officer



Dr. Jake P. Taylor-King

Director



Dr. Margaret Jackson

Head of Preclinical R&D



Dr. Martin Ducker

Director



Dr. Nafees Malik

Head of Cell and Gene Therapy



Dr. Raj S. Dattani

Director



Jim Mellon

Chairman



Yehudah Nevies

Associate Director



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References